PeptideStack
5.2kquestions
20kanswers
220users

What does 97.9% purity on a wide-pore C18 column actually tell me about a mazdutide vial?

Asked 19 Mar 2026Modified 2 months agoViewed 6k times
16

For reference: 97.9% · a wide-pore C18 column · mazdutide.

I want to understand what this actually establishes, as opposed to what it is being used to imply.

My concern is that I am being invited to draw a conclusion the data does not support.

What is the correct interpretation, and what is the common misreading?

hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

466 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
shareeditfollowflag
JE
askedjonas_ekstrom18k2819 Mar 2026
7Worth flagging that this changed in 2025, so older answers on the site are out of date. – petra_hovland 7 months ago
add a comment

2 Answers

Sorted by votes
9

Worth being precise here: the limit of this technique for these molecules is reaching a point where small improvements require proportionally large investments in method development.

System suitability checks on replicate injections of a known standard establish whether the method was in control — if the peak area varies by more than two per cent between replicates, something is wrong.

Sample preparation is almost always under-appreciated — a reconstituted peptide in strong solvent will distort its own peak on the gradient.

Inter-laboratory studies using identical methods on identical material show precision well within half a per cent when the method is locked down, pointing to method variability as the primary source of disagreement.

The practical summary: specify the method, run the same method on every sample you compare, and use orthogonal techniques to confirm the result.

shareimprove this answerflag
DS
answeredDr_Hanne_Solberg40k3810 Jun 2026
7The arithmetic checks out. I ran the same numbers and got the same result. – esben_lykke 3 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
6

The part that matters: the chemistry of peptides at low pH and high organic-solvent concentration is not something most users have intuition for, which is why published methods exist.

Reverse-phase stationary phases use C18 or C8 chains bonded to silica, and the pore size of the silica matters more for a peptide of this chain length than the ligand length does.

The underlying point is that detector linearity is why a heavily loaded peak can give false purity by compressing the main peak height while leaving impurity shoulders unchanged.

The selectivity of a reverse-phase separation depends on the hydrophobicity of the side-chain profile, which is why two peptides can co-elute even if they differ by a residue.

Ask for the chromatogram and the system suitability data, not just the number.

shareimprove this answerflag
TU
answeredtenth_of_a_unit40k3830 May 2026
6For what it is worth, my own result was within half a per cent of this. – u100_marks 8 months ago
5Any reason this would differ for a longer peptide? – ruaidhri_o_shea 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.